Related Experiment Video
Updated: May 9, 2026
10:58
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
Carbon nanotubes as vaccine scaffolds
David A Scheinberg1, Michael R McDevitt, Tao Dao
1Molecular Pharmacology and Chemistry Program, Departments of Medicine and Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.
Advanced Drug Delivery Reviews
|August 1, 2013
Summary
Carbon nanotubes show promise as vaccine scaffolds due to their stability, low toxicity, and ability to carry antigens. These properties make them effective carriers for vaccines against infectious diseases and cancer.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Immunology
Background:
- Carbon nanotubes possess unique properties suitable for biomedical applications.
- Developing effective vaccine delivery systems is crucial for combating diseases.
Purpose of the Study:
- To evaluate carbon nanotubes as scaffolds for vaccine development.
- To explore their potential as antigen carriers for infectious diseases and cancer.
Main Methods:
- Characterization of carbon nanotube properties relevant to vaccine development (stability, immunogenicity, toxicity).
- Assessment of antigen attachment capabilities.
- Evaluation of cellular uptake by antigen-presenting cells (e.g., dendritic cells).
Main Results:
- Carbon nanotubes demonstrate in vivo stability, low toxicity, and lack of intrinsic immunogenicity.
- They can be functionalized with multiple antigen copies.
- Efficient uptake by antigen-presenting cells was observed.
Conclusions:
- Carbon nanotubes are promising scaffolds for vaccine compositions.
- Their properties facilitate antigen delivery, showing potential for infectious disease and cancer vaccines.
